#1 Clinical Trials Search in Europe

Clascoterone

Clascoterone, a novel topical anti-androgen medication, is currently being studied in several clinical trials for its potential in treating acne vulgaris and androgenetic alopecia (male pattern hair loss). This article summarizes the ongoing research on clascoterone’s efficacy, safety, and potential applications in dermatology.

Table of Contents

What is Clascoterone?

Clascoterone is a new medication that has been developed to treat acne and hair loss. It’s also known by its brand name Winlevi[1]. Clascoterone is part of a class of drugs called topical anti-androgens, which means it works by blocking the effects of certain hormones on the skin[2].

How Does Clascoterone Work?

Clascoterone works by targeting the root causes of acne and hair loss. In acne, it helps to reduce the production of skin oil (sebum) and inflammation. For hair loss, it aims to block the effects of hormones that can cause hair follicles to shrink[3].

Specifically, clascoterone acts as a sebum inhibitor. Sebum is the oily substance produced by your skin that can contribute to acne when produced in excess. By reducing sebum production, clascoterone helps to prevent the formation of acne[4].

Conditions Treated by Clascoterone

Clascoterone is primarily used to treat two conditions:

  • Acne Vulgaris: This is the medical term for common acne. Clascoterone cream 1% has been approved for the treatment of acne in patients 12 years and older[1].
  • Androgenetic Alopecia: Also known as male pattern baldness, this is a common form of hair loss in men. Research is ongoing to determine if clascoterone can effectively treat this condition[5].

How is Clascoterone Administered?

Clascoterone is typically administered in two forms:

  • Cream: For acne treatment, clascoterone is available as a 1% cream. It’s usually applied twice daily to the affected areas of the skin[1].
  • Solution: For hair loss treatment, clascoterone is being studied as a 5% solution that is applied to the scalp twice daily[5].

Efficacy of Clascoterone

Several studies are currently underway to evaluate the effectiveness of clascoterone. For acne treatment, researchers are looking at various measures of success, including:

  • Reduction in the number of acne lesions (both inflammatory and non-inflammatory)[1]
  • Improvement in overall acne severity as assessed by doctors[6]
  • Patient-reported improvements in their acne[6]

For hair loss treatment, researchers are examining:

  • Increases in hair count[5]
  • Improvements in hair coverage as reported by patients[5]

Safety and Side Effects

As with any medication, clascoterone may cause side effects. Common side effects observed in studies include:

  • Redness of the skin (erythema)[6]
  • Dryness[6]
  • Peeling[6]
  • Itching (pruritus)[6]
  • Burning or stinging sensation[6]

It’s important to note that these side effects are generally mild and tend to improve with continued use of the medication. However, if you experience any severe or persistent side effects, you should consult your healthcare provider.

Ongoing Research

Several clinical trials are currently underway to further investigate the use of clascoterone:

  • Studies are examining the long-term safety and efficacy of clascoterone for acne treatment, including its use in patients with darker skin tones[6].
  • Researchers are investigating the potential of clascoterone to improve skin barrier function in acne-prone patients[7].
  • The effectiveness of combining clascoterone with other acne treatments, such as benzoyl peroxide and clindamycin, is being studied[8].
  • Large-scale trials are underway to evaluate clascoterone’s effectiveness in treating male pattern hair loss[5].

These ongoing studies will help to further our understanding of clascoterone and potentially expand its uses in treating skin and hair conditions.

Aspect Details
Primary Conditions Studied Acne Vulgaris, Androgenetic Alopecia (Male Pattern Hair Loss)
Formulations 1% cream for acne, 5% solution for hair loss
Application Method Topical, twice daily
Main Outcome Measures Acne lesion counts, hair count/coverage, skin barrier function
Safety Monitoring Skin irritation, dryness, local hormone changes
Additional Studies Pilonidal sinus disease, skin of color patients
Unique Features Topical anti-androgen, potentially fewer systemic side effects

FAQ

  • What is clascoterone and how does it work? Clascoterone is a topical anti-androgen medication that works by blocking androgen receptors in the skin. It is being studied for treating acne vulgaris and male pattern hair loss by reducing sebum production and potentially promoting hair growth.
  • What conditions is clascoterone being studied for? Clascoterone is primarily being studied for the treatment of acne vulgaris and androgenetic alopecia (male pattern hair loss). Some trials are also exploring its potential use in pilonidal sinus disease.
  • How is clascoterone applied in clinical trials? In most trials, clascoterone is applied topically as a 1% cream for acne or a 5% solution for hair loss. The medication is typically applied twice daily to the affected areas.
  • What are the main outcomes being measured in clascoterone trials? The main outcomes include changes in acne lesion counts, improvements in hair count and coverage for hair loss studies, and assessments of skin barrier function. Researchers are also evaluating safety, tolerability, and quality of life improvements.
  • Are there any known side effects of clascoterone? While the full safety profile is still being studied, some trials are monitoring for potential side effects such as skin irritation, dryness, and changes in local hormone levels. Overall, topical application appears to have a favorable safety profile compared to systemic anti-androgens.

Ongoing Clinical Trials on Clascoterone

  • Study on the Effectiveness and Safety of Clascoterone Solution for Treating Male Pattern Hair Loss

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland

Glossary

  • Acne Vulgaris: A common skin condition characterized by the presence of pimples, blackheads, and whiteheads, typically occurring on the face, chest, and back.
  • Androgenetic Alopecia: Also known as male pattern baldness, this is a common form of hair loss in men caused by a combination of genetic and hormonal factors.
  • Anti-androgen: A substance that blocks or reduces the effects of male hormones (androgens) in the body.
  • Clascoterone: A topical anti-androgen medication being studied for the treatment of acne and hair loss, also known by the brand name Winlevi.
  • Corneometry: A method used to measure the hydration level of the outer layer of the skin (stratum corneum).
  • Investigator's Global Assessment (IGA): A standardized scale used by researchers to evaluate the overall severity of acne or other skin conditions.
  • Pilonidal Sinus Disease: A chronic skin condition that usually occurs in the cleft of the buttocks and often becomes infected, forming a cyst or abscess.
  • Sebum: An oily substance produced by sebaceous glands in the skin, which can contribute to acne when produced in excess.
  • TEWL (Transepidermal Water Loss): A measurement of the amount of water that evaporates through the skin, used to assess skin barrier function.
  • Vehicle: In clinical trials, a placebo cream or solution that contains all ingredients except the active drug, used for comparison with the active treatment.

References

  1. https://clinicaltrials.gov/study/NCT06403501
  2. https://clinicaltrials.gov/study/NCT06454708
  3. https://clinicaltrials.gov/study/NCT06415279
  4. https://clinicaltrials.gov/study/NCT06425900
  5. https://clinicaltrials.gov/study/NCT05910450
  6. https://clinicaltrials.gov/study/NCT06415305
  7. https://clinicaltrials.gov/study/NCT06415292
  8. https://clinicaltrials.gov/study/NCT06336629